Venkatachalam K V, Ettrich Rudiger H
College of Allopathic Medicine, Nova Southeastern University, Ft. Lauderdale, FL, 33328, USA.
College of Biomedical Sciences, Larkin University, Miami, FL, 33169, USA.
Biochem Biophys Rep. 2021 Oct 18;28:101155. doi: 10.1016/j.bbrep.2021.101155. eCollection 2021 Dec.
3'-phosphoadenosine 5'-phosphosulfate (PAPS) is synthesized in two steps by PAPS synthase (PAPSS). PAPSS is comprised of ATP sulfurylase (ATPS) and APS kinase (APSK) domain activities. ATPS combines inorganic sulfate with α-phosphoryl of ATP to form adenosine 5'-phosphosulfate (APS) and PPi. In the second step APS is phosphorylated at 3'-OH using another mole of ATP to form PAPS and ADP catalyzed by APSK. The transfer of gamma-phosphoryl from ATP onto 3'-OH requires Mg and purported to involve residues DGDN. We report that mutation of either aspartic residue to alanine completely abolishes APSK activity in PAPS formation. PAPSS is an, unique enzyme that binds to four different nucleotides: ATP and APS on both ATPS and APSK domains and ADP and PAPS exclusively on the APSK domain. The thermodynamic binding and the catalytic interplay must be very tightly controlled to form the end-product PAPS in the forward direction. Though APS binds to ATPS and APSK, in ATPS domain, the APS is a product and for APSK it is a substrate. DGDN motif is absent in ATPS and present in APSK. Mutation of D and D did not hamper ATPS activity however abolished APSK activity severely. Thus, DGDN region is required for stabilization of Mg-ATP, in the process of splitting the γ-phosphoryl from ATP and transfer of γ-phosphoryl onto 3'-OH of APS to form PAPS a process that cannot be achieved by ATPS domain. In addition, gammaP-ATP, trapped phosphoryl enzyme intermediate more with PAPSS2 than with PAPSS1. This suggests inherent active site residues could control novel catalytic differences. Molecular docking studies of hPAPSS1with ATP + Mg and APS of wild type and mutants supports the experimental results.
3'-磷酸腺苷5'-磷酸硫酸酯(PAPS)由PAPS合酶(PAPSS)分两步合成。PAPSS由ATP硫酸化酶(ATPS)和APS激酶(APSK)结构域活性组成。ATPS将无机硫酸盐与ATP的α-磷酸基结合形成腺苷5'-磷酸硫酸酯(APS)和焦磷酸(PPi)。在第二步中,APS在3'-OH处被另一摩尔ATP磷酸化,在APSK催化下形成PAPS和ADP。γ-磷酸基从ATP转移到3'-OH需要镁离子,据推测涉及DGDN残基。我们报道,将任一天冬氨酸残基突变为丙氨酸会完全消除PAPS形成过程中的APSK活性。PAPSS是一种独特的酶,它与四种不同的核苷酸结合:在ATPS和APSK结构域上结合ATP和APS,在APSK结构域上仅结合ADP和PAPS。必须非常严格地控制热力学结合和催化相互作用,以正向形成终产物PAPS。尽管APS与ATPS和APSK结合,但在ATPS结构域中,APS是产物,而对于APSK来说它是底物。ATPS中不存在DGDN基序而APSK中存在。D和D的突变并不妨碍ATPS活性,但严重消除了APSK活性。因此,DGDN区域是稳定Mg-ATP所必需的,在从ATP裂解γ-磷酸基并将γ-磷酸基转移到APS的3'-OH以形成PAPS的过程中,这是ATPS结构域无法完成的过程。此外,γP-ATP与PAPSS2捕获的磷酸化酶中间体比与PAPSS1捕获的更多。这表明固有的活性位点残基可以控制新的催化差异。野生型和突变体的hPAPSS1与ATP + Mg和APS的分子对接研究支持了实验结果。